We are live on
!
Find out more
Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Mar ‘24 |
|
|---|---|---|---|---|---|
| $159M | $314M | $155M | 78.2% |
|
|
| $159M | $643M | $484M | 122% |
|
|
| $157M | $400M | $243M | 107% |
|
|
154
Alnylam Pharmaceuticals
ALNY
$39.9B
| $157M | $461M | $304M | 99.9% |
|
| $156M | $397M | $241M | 75.1% |
|
|
| $154M | $294M | $140M | 19.3% |
|
|
| $153M | $757M | $604M | 456% |
|
|
| $153M | $896M | $743M | 7.46% |
|
|
| $150M | $462M | $312M | 29.8% |
|
|
| $150M | $295M | $145M | 13.4% |
|
|
161
CRH
CRH
$70B
| $148M | $228M | $79.6M | 21.4% |
|
| $146M | $499M | $353M | 32.6% |
|
|
| $146M | $553M | $407M | 39.8% |
|
|
| $145M | $387M | $242M | 32.1% |
|
|
| $145M | $161M | $16M | 2,428% |
|
|
| $144M | $153M | $8.36M | 65.2% |
|
|
| $142M | $1.36B | $1.22B | 15.8% |
|
|
| $142M | $256M | $113M | 479% |
|
|
| $141M | $177M | $36M | 20.6% |
|
|
| $138M | $150M | $11.6M | 18.2% |
|
|
| $138M | $351M | $213M | 72.5% |
|
|
| $137M | $2.28B | $2.14B | 27.8% |
|
|
| $137M | $204M | $67.2M | 701% |
|
|
| $136M | $176M | $40.2M | 88.7% |
|
|
| $133M | $294M | $161M | 19.4% |
|